Abstract

Mammalian lignans or enterolignans are metabolites of plant lignans, an important category of phytochemicals. Although they are known to be associated with estrogenic activity, cell signaling pathways leading to specific cell functions, and especially the differences among lignans, have not been explored. We examined the estrogenic activity of enterolignans and their precursor plant lignans and cell signaling pathways for some cell functions, cell cycle and chemokine secretion. We used DNA microarray-based gene expression profiling in human breast cancer MCF-7 cells to examine the similarities, as well as the differences, among enterolignans, enterolactone and enterodiol, and their precursors, matairesinol, pinoresinol and sesamin. The profiles showed moderate to high levels of correlation (R values: 0.44 to 0.81) with that of estrogen (17β-estradiol or E2). Significant correlations were observed among lignans (R values: 0.77 to 0.97), and the correlations were higher for cell functions related to enzymes, signaling, proliferation and transport. All the enterolignans/precursors examined showed activation of the Erk1/2 and PI3K/Akt pathways, indicating the involvement of rapid signaling through the non-genomic estrogen signaling pathway. However, when their effects on specific cell functions, cell cycle progression and chemokine (MCP-1) secretion were examined, positive effects were observed only for enterolactone, suggesting that signals are given in certain directions at a position closer to cell functions. We hypothesized that, while estrogen signaling is initiated by the enterolignans/precursors examined, their signals are differentially and directionally modulated later in the pathways, resulting in the differences at the cell function level.

Highlights

  • We examined here the estrogenic activity of enterolignans and their precursors along with the signaling pathways involved in this action

  • To understand the estrogenic activity of enterolignans, we first examined the effect of enterolignans, enterodiol (ED) and enterolactone (EL), and their precursors, sesamin (SE), matairesinol (MR) and pinoresinol (PR) (Fig 1A), on the proliferation of ER-positive human breast cancer MCF-7 cells (Fig 1B, left panel)

  • EL showed an enhancement of cell proliferation equivalent to that for E2 at a statistically significant level, while the other enterolignans/precursors did not show such an enhancement

Read more

Summary

Methods

Rabbit antibodies against human cyclins D1 (#2978) and E (#4132), and cyclin-dependent kinase 4 (CDK4) (#12790), were obtained from Cell Signaling Technology (Danvers, MA). A mouse monoclonal antibody against human β-actin (#ab6276) was obtained from Abcam (Cambridge, United Kingdom). A horseradish peroxidase (HRP)-linked goat antibody against. Estrogenic signaling pathways for lignans rabbit IgG (#7074) and a horse antibody against mouse IgG (#7076) were obtained from Cell Signaling Technology. 17β-estradiol (E2; #E1132), SE (#S9314), ED (#45198), EL (#45199), MR (#40043), and PR (#40674) were obtained from Sigma-Aldrich (St. Louis, MO). ICI 182,780 was obtained from Tocris Bioscience (Bristol, United Kingdom). LY294002 was obtained from EMD Millipore (Billerica, MA)

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call